Nurix Therapeutics CFO Hans van Houte sells $74,474 of stock
Open the sourceReported by Investing.com, investing.com, 3 November 2026, by Investing.com
20Impact 20 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at investing.com.
Named in this story
Nurix Therapeutics, Hans van Houte